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The non-genomic effect has been considered to underlie the rapid action of steroids. This signaling
is initiated at the plasma membrane-level and does not directly inﬂuence gene expression. Recent
studies have provided detailed information on their downstream pathways, but less is known about
the nature of correlated membrane-bound receptors. Here, we propose that binding of steroids to a
consensus motif, namely CRAC, of G protein-coupled receptors (GPCRs) shifts the agonist-binding
state of receptors and accounts for this effect to a certain extent. The interaction between steroids
and GPCRs is speciﬁc, while the identities of the GPCRs involved are not restrained, which can coor-
dinate the high heterogeneity of this signaling and reconcile multiple discrepancies in the literature.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Steroid hormones (hereafter abbreviated as steroids), essential
components of the endocrine system, modulate many physiologi-
cal and pathological processes. They have long been recognized
to exert both rapid and delayed effects. The delayed effect, accord-
ing to the classical model of steroids action, is mediated by cyto-
solic steroid receptors, which takes a time lag of hours or even
days. These ligand–receptor complexes translocate into the nu-
cleus and regulate gene expression by binding to response ele-
ments in promoter regions. Steroids can also exert some rapid,
transcription-independent actions in seconds or minutes after
their application. These so called ‘non-genomic effects’ have been
noted for at least a half-century [2]. Non-genomic effects do not
inﬂuence gene expression, but drive more rapid biological actions
via signal transduction. Examples of these non-genomic effects in-
clude estrogen mediated blood vessel dilation, progesterone in-
duced acrosomal action and glucocorticoid triggered tracheal
relaxation [3].
There is growing body of evidence to suggest that these acute
actions are mediated by speciﬁc receptors localized most often to
the plasma membrane. Membrane impermeable steroid conju-
gates, such as BSA–steroid and polymer–steroid, can still perform
these rapid actions, which seem to be the most direct support forthe membrane-initiated steroid signaling (MISS). Although well-
deﬁned in several biological models, the nature of these receptors
is still elusive, triggering extensive research. The search for mem-
brane receptors has been ongoing for many years, and several can-
didates have been isolated via radio-labeled ligand–receptor
puriﬁcation from membrane fractions [4]. However, none of them
has been unequivocally conﬁrmed as the functional receptor. These
attempts were hampered by the lipophilic nature of steroids,
resulting in highly nonspeciﬁc binding [5]. Hitherto, several types
of candidates have been proposed for the non-genomic effects,
including classical steroid receptors localized in the plasma mem-
brane, traditional G protein-coupled receptors (GPCRs) and novel
membrane-associated steroid-binding proteins [6]. Approximately
5–10% endogenous estrogen receptor a (ERa) are present at the
plasma membrane that has been suggested to mediate the rapid
signaling of estrogen [7]. Compared to membrane localized classi-
cal steroid receptors, GPCRs are more appealing candidates (Ta-
ble 1). Pertussis toxin, which locks Gi protein in the GDP-bound
form, inhibits the non-genomic action of steroids in several models
which implies the involvement of G protein-GPCR signaling [8].
The GPCR hypothesis reached a peak when GPR30 was identiﬁed
as the membrane bound estrogen receptor with high afﬁnity,
although further evidence indicated its localization at the endo-
plasmic reticulum [9]. Furthermore, a GPCR-like protein, namely
membrane progestin receptor (mPR) has been isolated and charac-
terized by using one of the most relevant non-genomic effect mod-
els, steroid-induced oocyte maturation [10]. To reconcile the
existing data, perhaps both classical steroid receptors and newly
Table 1
Steroid hormones, non-genomic effects and speciﬁc GPCRs possibly involved.
Steroid Non-genomic effect Speciﬁc GPCR
Estrogen Vasodilitation
Breast cancer, endometrial cancer and ovarian cancer cell proliferation and survival
GPR30 [9]
Progesterone Fish oocyte maturation mPR [10]
Androgen Prostate cancer cell proliferation and survival
Frog oocyte maturation
GPRC6A [11]
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ing on the biological processes and involved steroids. But the ques-
tion of how these highly hydrophobic steroids speciﬁcally interact
with GPCRs that contain no known steroid-binding domain has not
been answered.
To address this concern, we provide a novel and provocative in-
sight toward the interaction between steroids and GPCRs, in trying
to explain non-genomic effects of steroids.
2. The hypothesis and evaluation
Although no conserved steroid binding pocket has been recog-
nized in GPCRs, a consensus binding motif was deﬁned for choles-
terol, which shares the mother nucleus with steroids. This motif,
named cholesterol recognition/interaction amino acid consensus
sequence (CRAC), was ﬁrst recognized in the peripheral-type ben-
zodiazepine receptor [12]. In addition to biochemical character-
ization, the existence of this binding motif was further
conﬁrmed when the crystal structure of human b2 adrenergic
receptor-cholesterol was resolved [13]. In this structure, choles-
terol did not dock to the ligand-binding pocket of GPCR, but
bound in a shallow groove formed by segments of helices I, II,
III and IV, which in the view of structural biology enhanced the
thermal stability. The interaction was deﬁned by four spatially
distributed amino acids, and further alignment analysis revealed
that CRAC was conserved in about one-third of class A GPCRs.
This implies that cholesterol binding inﬂuences the properties
of GPCRs. Indeed, modulatory effect of cholesterol has been dem-
onstrated for the oxytocin receptor, in which cholesterol not only
enhanced its thermal stability but shifted the receptor to a high-
afﬁnity binding state. Moreover, a variety of sterol analogues have
also been shown to regulate the agonist-binding afﬁnity of the
oxytocin receptor [14]. Steroids, derived from cholesterol with
partial cleavage of the carbon-17 side chain, are considered to
be more ﬂexible ligands for the binding site. In the light of these
data, we propose that the non-genomic effect of steroids is med-
iated by the interaction between steroids and GPCRs via CRAC,
which further inﬂuences the receptor activity. The interaction be-
tween steroids and CRAC is speciﬁc, while the GPCRs involved
need not be speciﬁc, i.e. dozens of GPCRs bearing CRAC will be
regulated by the steroids. This pan-interaction can accommodate
the unexplained controversies in literatures: (i) different steroids
can exert a similar non-genomic effect, as both progestin and
androgen can promote oocyte maturation [6], (ii) for a single ste-
roid, various downstream signaling pathways have been impli-
cated, including adenylate cyclase-protein kinase A (PKA) or
phospholipase C (PLC)-protein kinase C (PKC) [3], (iii) different ef-
fects are initiated by same steroid in various models, which can
be explained by the compositional difference of GPCRs’ pool ex-
pressed in distinct cell types, and (iv) there is no strict enantiose-
lectivity for the steroid effect [15] in accordance with the
observed promiscuity of cholesterol-binding site for a series of
sterol analogues [14]. This hypothesis can be regarded as a gen-
eral mechanism to explain the highly variable non-genomic ef-
fects and also the multiple failures in the search for speciﬁc
membrane receptors for most steroids.Given the lipophilic nature of steroids, their inﬂuence on
membrane ﬂuidity and curvature may also contribute to the
non-genomic effect via GPCRs. As seven transmembrane proteins,
GPCRs’ activity is also regulated by the microenvironment formed
by lipid bilayers. It has been well-established that cholesterol–
rhodopsin interaction can promote a photon receptor shift be-
tween different intermediate states [16]. Steroids can also imitate
this effect.
3. Conclusions
The non-genomic effect of steroids is highlighted as a mem-
brane-associated signaling, which makes it distinct from the
classical steroid action on gene expression. We propose that
the speciﬁc interaction between steroids and CRAC of uncon-
strained GPCRs accounts for this effect to some extent. This
can also be attributed to their inﬂuence on biophysical proper-
ties of the plasma membrane. We hope this hypothesis can pro-
vide a novel insight for the allosteric regulation of steroids
signaling.
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